Skip to main content
NBIX
NASDAQ Life Sciences

Neurocrine Jumps 15% on Third Straight Double Beat and Second Ingrezza Guidance Hike

Tom Rudovsky · Reported by Seeking Alpha
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$168.29
Mkt Cap
$17.107B
52W Low
$122.138
52W High
$186.12
52W Position info
38% above low
Off High info
9.6% below high
Rel. Volume info
2.1× avg
Market data snapshot near publication time

NBIX sits 38% above its 52-week low of $122.138 on elevated volume (2.1× avg).

Summary

Neurocrine posted Q3 revenue of $1.1B, up about 41% year over year and $80M above consensus, with non-GAAP EPS of $3.29 beating by $0.54. That is the third consecutive double beat. Management raised 2026 Ingrezza sales guidance for the second time this year, to $2.9B-$2.925B from $2.83B-$2.88B, topping the $2.86B consensus. The stock is up more than 15% intraday, its biggest one-day gain in six years, following the 8-K and 10-Q filed last night. Diversification is showing: Crenessity and Vykat XR accounted for 28% of Q3 revenue, and Stifel lifted its target to $217 from $215 while Wedbush held $186. The open question is whether the Ingrezza raise holds as the franchise matures and generic pressure builds.

At the time of this announcement, NBIX was trading at $168.29 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $17.1B. The 52-week trading range was $122.14 to $186.12. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Seeking Alpha.


Price Chart

Share this article

Copied!

NBIX - Latest Insights

NBIX
Nov 02, 2026, 4:50 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $157.48
Real-time Price: $150.54 info
Change: -$6.94 (-4%) info
Market Cap: $15.306B info
NBIX
Nov 02, 2026, 4:14 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $146.96
Real-time Price: $150.54 info
Change: +$3.58 (+2%) info
Market Cap: $15.306B info
NBIX
Nov 02, 2026, 4:11 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $145.35
Real-time Price: $150.54 info
Change: +$5.19 (+4%) info
Market Cap: $15.306B info
NBIX
Aug 26, 2026, 3:33 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $153.37
Real-time Price: $150.54 info
Change: -$2.83 (-2%) info
Market Cap: $15.306B info
NBIX
Aug 03, 2026, 7:33 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $167.40
Real-time Price: $150.54 info
Change: -$16.86 (-10%) info
Market Cap: $15.306B info